ZKB/PUT/ROCHE GS/215/0.02/27.09.24 Share Price

Warrant

ROGPAZ

CH1281035688

Real-time Bid/Ask 08:00:33 28/06/2024 BST
0.02 CHF / 0.03 CHF -16.67% Intraday chart for ZKB/PUT/ROCHE GS/215/0.02/27.09.24
Current month-60.00%
1 month-57.14%
Date Price Change
21/06/24 0.03 -14.29%

Delayed Quote Swiss Exchange

Last update June 21, 2024 at 04:20 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying ROCHE HOLDING AG
Issuer ZKB
ROGPAZ
ISINCH1281035688
Date issued 19/10/2023
Strike 215 CHF
Maturity 27/09/2024 (92 Days)
Parity 50 : 1
Emission price 0.18 CHF
Emission volume N/A
Settlement Ambos
Currency CHF

Technical Indicators

Highest since issue 0.23 CHF
Lowest since issue 0.03 CHF
Delta-0.09x
Omega 17.30
Premium14.7x
Gearing200.48x
Moneyness 0.8579
Difference Strike -36.65 CHF
Difference Strike %-17.05%
Spread 0.01 CHF
Spread %33.33%
Theoretical value 0.0250
Implied Volatility 24.05 %
Total Loss Probability 89.35 %
Intrinsic value 0.000000
Present value 0.0250
Break even 213.75 CHF
Theta-0x
Vega0x
Rho-0x

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
250.4 CHF
Average target price
278.1 CHF
Spread / Average Target
+11.04%
Consensus
  1. Stock Market
  2. Warrants
  3. ROGPAZ Warrant